Abstract
A novel melanogenesis inhibitor, byelyankacin (1), was isolated from the fermentation broth of a bacterial strain. The producing organism, designated B20, was identified as a member of the genus Enterobacter based on taxonomic characteristics. 1 was obtained as a white powder from the culture medium by solvent extraction and serial chromatographic purification. The structure of 1 was determined as (E)-4-(2-isocyanovinyl)phenyl α-L-rhamnopyranoside on the basis of spectroscopic data. 1 potently inhibited mushroom tyrosinase and melanogenesis of B16-2D2 melanoma cells with IC50 value of 2.1 nM and 30 nM, respectively.
| Original language | English |
|---|---|
| Pages (from-to) | 717-720 |
| Number of pages | 4 |
| Journal | Journal of Antibiotics |
| Volume | 60 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- B16-2D2 melanoma cell
- Byelyankacin
- Enterobacter sp.
- Melanogenesis inhibitor
- Mushroom tyrosinase
Fingerprint
Dive into the research topics of 'Byelyankacin: A novel melanogenesis inhibitor produced by Enterobacter sp. B20'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver